Thursday, November 21, 2013

Morning Call | 21 November 2013


FLOWS
Thursday, 21 November, 2013
BUY
IOICORP, FGV, AXIATA
SELL
DIALOG, GENM, TENAGA
STOCK ALERT
STOCK NAME
DATE
PRICE
BUY/SELL
TARGET PRICE
HOVID (7213)
21/11/2013
RM0.345
ACCUMULATE on weakness
RM0.41
We continue to like Hovid for its defensive earnings as this pharmaceutical company covers more than 350 different types of generic drugs, OTC and dietary supplyments which are exported to more than 45 countries worldwide. Moving forward Hovid’s earning growth will be fuelled by new product launches (10-15new products annually). The Next 5 years would be an interesting period for the group as they will benefit from the “patent cliff” where the patent expiration of drugs worth US133bn expires allowing drugmakers to launch generic version of this drug to expand sales. Another rerating catalyst for Hovid is its on-going prospect to achieve US FDA approval for its patented product, the Palm Tocotrienols, that’s expected to be completed in 2-3 years. Currently stock is only trading at 12.7x FY13 PE and 10.7x for FY14. P/b Value is only 1.6x which is relatively lower than regional average of 4x. Earnings growth will come from the plan expansion of their Ipoh plant in 2014. Technical chart has fulfilled its h&s breakdown tp (3.5sens from RM0.36) yesterday and found support at lower levels. RSI is approximately 53%. Accumulate on weakness with a TP of RM0.41 based on 12x PE for FY14 and 0.032 EPS.
(RL)
 

TSH (9059)
21/11/2013
RM2.83
Take Profit
RM2.50
In light of the CPO stocks rally recently, the stock has done well gaining 18% to a high of RM3.00 (surpassing our target price of RM2.98) in the past 5 trading days after Dorab Mistry pegged RM2,800 pmt target for the first half of next year ahead of the implementation of B7 in Biofuel. While, the policy has yet to see any development, CPO prices would likely consolidate till the end of year. Recent news flow also reveals that our country has increased export tax for the first time in 9 months for December to 5% from 4.5% and would curb rising export numbers. Given that TSH is a close beta to plantation prices, we feel it’s appropriate to take profit. Fundamentals are still intact as group has a young plantation profile (77% of trees are below 7 years mainly in Sabah and Sarawak) and 19% CAGR supported by its decent FFB growth. We think a buyback is in order around the RM2.50 level which is 15.6x for PE FY14. 
(RL)
 
 

Calls for  NOV Week 2
STOCK
Initiation Dates
Initiation price
BUY/SELL
TARGET PRICE
LAST PRICE
% Change since Initiated
NAIM (5073)
14/11/2013
RM3.56
ACCUMULATE
RM5.12
RM3.69
+3.6%
ALAM (5115)
14/11/2013
RM1.40
Technical BUY
RM1.68
RM1.57
+12.1%
WASEONG (5142)
15/11/2013
RM1.70
ACCUMULATE
RM2.00
RM1.68
+1.2%
PERDANA (7108)
15/11/2013
RM1.94
BUY
RM2.30
RM1.99
+2.5%
TM(4863)
18/11/2013
RM5.16
Trading BUY
RM5.90
RM5.18
-0.3%
SWKPLNT(5135)
18/11/2013
RM2.50
BUY
RM2.90
RM2.56
+2.4%
MAYBULK (5077)
19/11/2013
RM1.71
BUY
RM2.00
RM1.74
+1.7%
FGV (5222)
19/11/2013
RM4.30
BUY
RM4.93
RM4.52
+5.1%
MATRIX (5236)
20/11/2013
RM3.24
Trading SELL
RM2.90
RM3.20
+1.3%
GADANG (9261)
20/11/2013
RM0.99
BUY
RM1.41
RM0.975
+1.6%

 

HOLD
CONT SELL
SELL/ TAKE PROFIT
CONT BUY
STRONG BUY